Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. [electronic resource]
- Circulation Oct 1989
- 749-56 p. digital
Publication Type: Journal Article; Review
0009-7322
10.1161/01.cir.80.4.749 doi
Aspirin--adverse effects Biomechanical Phenomena Cardiovascular Diseases--prevention & control Gastrointestinal Diseases--chemically induced Humans Myocardial Infarction--prevention & control Platelet Aggregation Inhibitors--therapeutic use Recurrence Risk Factors